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Introduction
ST93 genomes. For our study, we considered the most interesting variants to be the "allST93" or 149 "someST93" because these categories would potentially identify variants that could explain the 150 increased overall pathogenesis of ST93 in humans (category iii), and will allow us to identify 151 variants within ST93 associated with human clinical outcomes and phenotypes (category iv).
153
Common variants in ST93 154 Variants that are in all ST93 strains and not the other sequenced strains (or the reference 155 genome) can potentially tell us something about what differentiates strains in ST93 from other 156 Ugandan strains. We identified 5110 variants common to all 38 ST93 genomes (4681 SNPs and 157 429 small indels). These variants were dispersed across the genome, associated with 2575 genes 158 and 140 hypothetical RNAs (Figure 3 , Table S1 ). The majority of these genes have one or a 159 small number of variants, while a handful of genes had a very high number of variants (Table S2 , 160 23 genes with at least 10 variants). The percentage of named genes in this set (8%, 2 of 24) 161 matches the full gene set (8%, 686 out of 8338). The number of genes with a description (i.e., not 162 "hypothetical protein" or "hypothetical RNA") is actually lower in this gene set (33%) than the 163 whole gene set (49%). 164 165 ST93 clade-specific variants 166 Our primary aim was to identify the variants that are in some, but not all of the ST93 167 genomes, as these are the variants that can be used to examine genome associations with the 168 measured human clinical phenotypes. When we examine the phylogenetic tree of ST93 COAT 169 strains, we surprisingly identified a well-supported split between ST93 strains ( Figure 2B) , with 170 20 of the sequenced strains in one group ("clade A"), 16 strains in a second ("clade B"), and two 171 ST93 strains outside of the primary clades. We identified 97 variants that differentiate strains in 172 one clade from the other: 60 variants were unique to and in all clade A strains, and 37 variants 173 were unique to and in all clade B strains. Clade-specific variants were located throughout the 174 genome ( Figure 4A ) in 96 different genes. All except for one of the genes contained only a single (Table S3 ). Although the majority of these variants are in genes 180 that have not been characterized, four are in genes of known function: LIV11 (CNAG_05422), a 181 virulence protein of unknown function, HSX1 (CNAG_03772), a high-affinity glucose 182 transporter; PTP2 (CNAG_05155), a protein tyrosine phosphatase; SPT8 (CNAG_06597), and a 183 predicted saga histone acetyltransferase complex component.
185
Variant association with human clinical, immunologic and in vitro phenotypes 186 We next determined whether variants in the ST93 strains were associated with clinical 187 measures of disease, CSF cytokines levels, or with in vitro phenotypes [30, 40] , (Table 1 , see 188 Methods for more details). We collectively refer to these three classes of phenotypes as 189 "quantitative infection phenotypes". We identified a significant correlation between the ST93 190 A/B clade with in vitro macrophage uptake rate and patient CSF interleukin (IL)-2 (non-191 parametric Wilcoxon rank sum test; uptake W = 226, p = 0.011; IL2 W = 66.5, p = 0.022; Figure   192 4C). There was not a significant relationship between ST93 clade and the other quantitative 193 infection phenotypes ( Figure S1A ; non-significant t-test results in Table S4 ), nor between ST93 194 clade and survival ( Figure S1B , Fisher-exact test, p = 0.33).
195
To examine associations between single variants and quantitative infection phenotypes 196 (our primary objective), we parsed the 5605 variants that were in some (but not all) of the ST93 197 genomes. We took two complementary approaches to look for phenotypic associations. Our first 198 tactic was to treat each measured phenotype as independent. For the second we used principal 199 components analysis (PCA) to distill the 30 measured phenotypes into a smaller number of 200 independent variables. Due to the nature of data collection for these types of phenotypic data, 201 some strains were missing data for some phenotypes (Table S5 ). The most consequential was 202 two strains missing data for all cytokine phenotypes.
203
For the first tactic we analyzed phenotypes in each class as independent datasets in a 204 logistic regression approach ( Figure 5 ). For each, we removed variants that were in very few 205 (<4) strains, as well as those without a predicted function (i.e., synonymous and intergenic 206 variants), and those that mapped to either the centromeric or extreme telomeric regions. This left 207 us with 466 variants in 230 genes for the cytokine dataset and 652 variants in 328 genes for the 208 clinical and in vitro datasets. For each dataset we then conducted logistic regression analyses for 209 each variant against each phenotype and found that across all tests 207 variants from 115 different genes were significant for at least one phenotype. The majority (138 variants) were 211 significant for a single phenotype. To partially correct for false positives, we focused our further 212 analyses only on the variants that were significant for at least two phenotypes ("class a") or when 213 multiple significant variants were identified in the same gene ("class b"), or when the variant 214 fulfilled both criteria ("class ab"). This narrowed the list to 145 variants from 40 genes and 3 215 hypothetical RNAs, with 13 variants in class a, 36 variants in class b, and 96 variants in class ab 216 ( Table 2 , full information about significant variants including class in Table S6 , full statistical 217 information for each significant variant and phenotype in Table S7 ).
218
Following the default parameters in SnpEff, we used a very broad definition for calling 219 variants upstream or downstream variants (+/-5 kb). Over 80% of the significant variants were 220 either upstream or downstream of genes (86 variants upstream, 34 variants downstream), with 221 20% within 1 kb (Table S6 ). Of the remaining variants, 21 were nonsynonymous, while 4 were 222 indels. The majority of significant genes contained multiple significant variants ( Table 2 ). In 223 some cases, different variants in the same gene influenced the same phenotype, generally 224 because the multiple significant variants are linked (e.g., three nonsynonymous variants in 225 CNAG_00014 with the majority of ST93 strains falling into two haplotypes; one upstream SNP 226 and two upstream insertions in CNAG_02112 with two haplotypes that influenced amphotericin 227 B resistance). In other cases, such as CNAG_07950, there were six different haplotypes and 228 three significant upstream variants that were associated with 8 unique phenotypes (IL8 was 229 associated with the two variants, while HIVrna, IL4, IL6, GMCSF, IFNγ, Fluconazole MIC, and 230 EFA were each associated with a single variant). 231 We also conducted PCA analysis as a second tactic to reduce the potential influence of 232 phenotypic correlation on the results ( Figure 5 ). As PCA requires complete datasets, we used 233 data from the 27 phenotypes that had missing data from only three or fewer strains (i.e., we 234 excluded CrAg LFA titer, HIV RNA viral load, CSF protein, and CSF white cell data, Table S5 ) 235 and had to exclude 8 strains (UgCl212, UgCl332, UgCl357, UgCl422, UgCl447, UgCl461, 236 UgCl541, UgCl549, Table 1 ). The 'prcomp' function from the R programming language was 237 used to perform PCA on the two phenotypes which were scaled to have unit variance and shifted 238 to be zero centered. We continued with the first two principal components by comparing the 239 observed results to 20 datasets where the phenotypic data was randomized among strains ( Figure   240 S2A). Logistic regression analysis was run for each of the 466 variants that passed filter against 241 PC1 and PC2. The PCA analysis yielded only 16 significant variants in 12 genes (Table 3 ). Only 242 one of these genes, CNAG_07727, was not identified in the first analysis, and twelve of these 243 variants were previously significant.
244
The majority of genes with a high number of significant variants were also genes with 245 high numbers of sequenced variants and potentially-significant variants ( Figure 6 ). In addition to 246 variation among genes in regards to the number of significant variants within a gene ("sig 247 variants"; ranging from 1-34), there was also variation in the number of variants that were 248 identified within a strain ("sequenced variants"; range: 1-210) and the number of variants that 249 passed our filters ("potentially-significant variants": range: 1-32). This result highlights a 250 limitation of genetic association screens such as the one we performed. Without additional 251 biological validation it is difficult, if not impossible, to ascertain whether a given gene has many 252 significant variants because of strong selection acting on that gene (e.g., if a knockout phenotype 253 is beneficial there are many different positions that can reduce gene expression or protein levels) 254 or because of relaxed selection and chance (i.e., if there is relaxed selection then many variants 255 could be present, with statistical significance arising by chance). However, the fact that we do 256 see areas of discordance between all the sequenced variants, potentially significant variants, and 257 significant variants suggests many of our significant variants are not just a statistical artefact. Table 4 , significantly different strains in Figure 7 , non-significant strains in Figure S3 ). Although 271 gene deletion mutants are only one way to biologically probe whether a candidate gene has a true virulence phenotype, we did find that the number of significant variants in a gene (Table 2 ) was a 273 significant predictor of the deletion mutations having a virulence effect (linear model, F1, 15 = 274 8.493, p = 0.011).
276
In vivo and in vitro analysis of itr4 and clinical strains 277 The gene with the highest number of significant variants in our candidate gene list was 278 CNAG_05662 (ITR4), which has been reported as a member of the inositol transporter gene 279 family [59] . The itr4Δ mutant strain had reduced virulence in the mouse model whereas the days post-infection showed more itr4 mutant CFUs in the lungs than KN99 and itr4Δ:ITR4, 288 and no itr4 CFUs in the brain ( Figure S4 ), suggesting the reduced pathogenesis observed in the 289 itr4Δ mutant is likely due to reduced growth in or delayed dissemination to the brain.
290
To further determine the role of the genetic variants in the biological function of ITR4 -291 KN99 , itr4Δ, and three clinical strains (UgCl389, UgCl462, and UgCl443) were tested for 292 growth with inositol and inositol uptake. The variants associated with the ITR4 locus in these 293 clinical strains are proximal to the coding region -both UgCl389 and UgCl462 have 11 single 294 nucleotide polymorphisms immediately downstream of the coding region whereas UgCl443 295 contains the H99 reference allele for ITR4 ( Figure 8B ). All the clinical strains showed enhanced 296 growth with inositol compared to KN99 , and similar to itr4 ( Figure 8C ). UgCl389 and 297 UgCl462 were also more efficient at inositol uptake, while UgCl443 was similar to KN99 , and 298 itr4 had decreased inositol uptake ( Figure 8D ). Taken together, these data highlight the Virulence is a multifaceted phenotype, as many different pathogen and host 305 characteristics will determine the severity of a given infection. Here we paired a powerful dataset 306 from the Cryptococcal Optimal ART Timing (COAT) trial in Uganda with pathogen whole 307 genome sequencing technology to identify candidate C. neoformans genes that were statistically 308 associated with quantitative human infection phenotypes. The technique of using Genome-wide 309 Association Studies (GWAS) to uncover genic variants linked to disease was developed fourteen 310 years ago in the context of human disease genetics [46] . Here we looked for association between 311 variants within 38 ST93 C. neoformans isolates from participants enrolled in the COAT trial 312 with 30 measured clinical phenotypes, cytokines, and in vitro phenotypes. We took two 313 complementary tactics to identify candidate genes. The first treated each measured phenotype as 314 independent, yet only included genes that either have a variant significantly associated with 315 multiple phenotypes (13 genes), genes with multiple significant variants (10 genes), or both (20 316 genes). We also conducted a PCA analysis examining the first two principal components from a 317 PCA on the 27 phenotypes and 30 strains with sufficient data. The resultant reduction of power 318 is unfortunate, but not surprising when dealing with human data, and the detrimental impacts of 319 missing clinical data have been previously discussed [47] , and indeed is why we took both 320 tactics. The PCA analysis yielded a total of 12 genes, 11 that overlapped with those identified in 321 the first analysis and one additional gene. Combined, we identified 40 candidate C. neoformans 322 genes and three hypothetical RNAs associated with infection phenotypes among the ST93 323 strains.
324
The statistical analysis is blind to any prior knowledge of the genes, and thus does not 325 depend on prior annotation. Accordingly, the majority of genes we identified have not yet been (Table S8 ). This is consistent with the logic of Liu et al. [7] , who purposefully 331 targeted genes that did not have homologues in Saccharomyces cerevisiae during the construction of the original H99 gene deletion collection [14] (an 1180 gene collection in C. 333 neoformans H99, which corresponds to ~20% of the protein coding genes). 334 We took advantage of the newer KN99 gene deletion collection [48] and found that 335 35% (6/17) of the available gene knockouts had an effect on virulence in mice. The significant 336 genes with a virulence change in mice include two named genes ITR4 (CNAG_05662) and APP1 337 (CNAG_06574) as well as three hypothetical proteins from closely related species 338 (CNAG_02176, CNAG_04922, CNAG_06332) and one hypothetical protein with broad 339 taxonomic distribution (CNAG_06968). APP1 is a cytoplasmic protein involved in extracellular 340 secretion and reduced phagocytosis. The app1Δ mutant has previously been shown to have 341 decreased virulence in mice [49] . Interestingly, this is opposite from our mouse model that 342 showed increased virulence of the app1Δ mutant. This difference could be due to the differential 343 immune response in BALB/C (previous study, type 1 immune response) and C57Bl/6 mice 344 (current study, type 2 immune response) that likely gives a hint to the mechanism of APP1 in 345 human disease. 346 Intriguingly, ITR4 (synonym PTP1) was the top hit in a screen that identified genes that 347 were overexpressed in an intracellular environment (amoebae and murine macrophages) 348 compared to the lab medium YPD [50] . In that study, itr4Δ did not differ from wildtype in mice 349 or Galleria mellonella virulence assays [50] , though these studies were performed in a different 350 genetic background from our KN99 reference strain. Using gene complementation, we clearly 351 show the virulence defect in the itr4Δ mutant is due to deletion of the ITR4 gene. However, our 352 analysis of differences in growth and uptake of inositol in clinical isolates with different variants 353 was less conclusive. All of the clinical strains appeared to be better adapted for growth and 354 uptake of inositol compared to the KN99 reference strain. This is not surprising, given that the There was no clear relationship between genes that were identified in both of our 364 statistical analyses and the gene deletion virulence in mice (five genes were significant in both, 365 two with a significant gene deletion virulence effect, Table S8 ). We note, however, that although 366 there is a good link between strain survival in mice and human virulence [24] , there are two 367 major limitations with interpretation and extrapolation of the virulence tests we performed in this 368 study. The first is that the phenotype of a gene knockout does not necessarily recapitulate the 369 effect of a natural point or indel mutation (e.g., [51] [52] [53] ). Importantly, variants located upstream 370 of a gene were extremely prevalent in our dataset, suggesting that they would not be 371 phenocopied with a gene deletion if an increase in expression is required to influence the trait.
372
The second reason for pause is that the gene knockout collection is in the KN99 genetic 373 background. It has previously been shown that although ST93 and KN99 are both VNI strains, 374 they are phylogenetically quite distantly related [10] . We see this distance in our own dataset: 375 2941 variants were present in the closely related ST93 genomes we sequenced and over 40 000 376 variants were present across all the genomes compared to the H99 reference strain. Genetic 377 background is known to play a significant role on the effect of a mutation. A large study in 378 Saccharomyces cerevisiae recently found that 16-42% of deletion phenotypes changed between 379 pairs of strains, depending on the environment [54] . To fully probe the influence of the variants 380 and genes we identified in our screen these variants need to be studied in the ST93 background.
381
Given these limitations, we anticipate additional studies will uncover more genes from our study 382 with an impact on pathogenesis. It would also of course be of general interest to reconstruct a 383 knockout collection in a strain background more representative of typical clinical strains [14, 28] . 384 We purposefully chose to focus our study on strains from ST93, which was the most 385 prevalent ST group from strains we sampled from participants in the COAT trial (~63% of all 386 strains). ST did not significantly influence mortality (ST93: 22 patients died, 24 survived; non-387 ST93: 9 patients died, 16 survived; fisher-exact test p = 0. 45). ST93 was similarly the most 388 prevalent among advanced HIV patients in Brazil [25] . By contrast, ST93 isolates were less 389 common than ST5 isolates among immunocompetent patients in Vietnam, and non-ST5 strains 390 were associated with decreased mortality compared to ST5 [55] . Other studies have found no 391 ST93 isolates [56, 57] . This picture of geography having a major impact on which group is most 392 prevalent begs the question of whether it is merely chance or the effect of selection that sorts 393 lineages geographically.
As additional 'genome enabled' clinical datasets are constructed, we can hope to gain a 395 clearer global picture about the link between broad and narrow genomic variability on clinical 396 outcome. Our narrow analysis in the ST93 strains was possible because of the large number of 397 patients infected with this sequence type in Uganda. Only as similar studies are performed in 398 patient populations throughout the world, with other dominant STs, or in the context of increased 399 genetic diversity, will we be able to determine how broadly applicable our study is to the global 400 population of C. neoformans. 401 Statistical association techniques using human clinical data, such as those employed here, 402 offer a complementary approach to genetic screens of mutant collections. They offer the benefit 403 of not having to choose a particular strain background to focus your efforts (typically the 404 reference strain), nor make decisions about which genes are likely to be the most important. For 405 example, the genes chosen for the initial C. neoformans knockout collection were biased not only 406 against genes with homologs in S. cerevisiae, but also against C. neoformans-specific genes [7] .
407
There are also inherent biases to forward genetics methods. Here we only have the statistical 408 power to find association with common variants. The majority of variants we sampled among 409 our strains were singleton variants in only a single genome ( Figure 1A) , and some of these may 410 well have an extremely important influence on virulence that remains undetected in our current 411 analysis. Hence we have treated our pathogen GWAS analysis like a genetic screen, and the true 412 utility of this type of analysis is not seen in just one study in isolation of others. The power lies in 413 the opportunity to compare among studies of different types to find candidate genes or alleles to 414 focus our attention on.
415
Our analysis did not identify variants in many of the genes that were previously identified 416 through in vitro and in animal mutant screens as virulence factors in C. neoformans, such as 417 genes involved in capsule formation and melanin synthesis. There could be several reasons for 418 this result. Importantly, all of the ST93 strains analyzed were isolated from patients with 419 cryptococcal meningitis, thus all these strains by definition are capable of causing disease and in 420 our study the readout was not presence or absence of disease but rather the severity of disease.
421
Previous studies may have identified virulence factors involved in the early stages of infection 422 that impact the ability of C. neoformans to infect and then survive within the host, whereas our 423 study identified virulence factors that promote or inhibit the progression of disease. Second, our 424 analysis utilized human clinical data for association with genetic differences between strains 425 whereas previous studies utilized surrogates, either in vitro conditions or animal models. By 426 studying genetic differences in the context of human infection, we have the potential to not only 427 define genes that promote disease in humans but also the potential to define aspects of the host-428 pathogen interaction that are specific to C. neoformans and the human host. Optimal ART Timing (COAT) trial [30] . We focused primarily on 38 UgCl ("Ugandan 445 Clinical") COAT strains that had previously been MLST genotyped as sequence type 93 (ST93), 446 the most prevalent ST group in this collection of strains [31] . An additional 18 strains from ten 447 MLST groups were also whole genome sequenced to represent strain diversity in Ugandan 448 clinical isolates [9] . 449 Clinical isolates were colony purified from the CSF of participants that presented at the 450 clinic with their first episode of cryptococcal meningitis. The ST93 clinical isolate strains were 451 purposefully chosen to represent strains from both participants who survived (n=21) and died (n 452 = 17). As with the parent COAT trial, survival was decreased with early ART initiation, all 453 putative ST93 clinical isolates used for these studies were from the standard-of-care (deferred 454 ART treatment) arm of the clinical trial. Patient infection phenotypes (i.e., clinical and cytokine 455 parameters, Table 1 ) were measured on the day patients were diagnosed with cryptococcal 456 meningitis, prior to antifungal or ART treatment. Cytokine data was log2 transformed prior to 457 analysis, as described previously [32] . 
Library Preparation and Illumina Sequencing
Biomarkers analyzed as continuous variables were log2 transformed for normalization, 554 analyzed, and then back-transformed to geometric mean values. All "mean" biomarker values are 555 geometric means. Low ("out of range") measurements were set to half of the manufacturer's 556 listed assay limit of detection (LOD). CSF biomarkers with substantial proportions (≥40%) of 557 undetectable values at diagnosis (IL-2, IL-1β, IL-5, CCL22) were analyzed as categorical 558 variables: "detectable" (values greater than the LOD) versus "nondetectable (values lower than 559 the LOD). CSF white blood cell count (WBC) was analyzed as absolute values and also 560 classified as "normal" versus "elevated" (<5 vs ≥5 cells/µL, respectively). defined as 20% total body weight loss, loss of two grams of weight in two days, or symptoms of 573 neurological damage. On day 34, the remaining mouse was sacrificed. Lungs and brain were 574 removed and homogenized in 4 mL or 2 mL PBS, respectively. Serial dilutions of the lungs and 575 the entire homogenized brain were plated on YPD with chloramphenicol. CFUs were counted 576 after 48 hours.
577
Significance was determined using the survfit command from the R package survival 578 [43] . Kaplan-Meier estimators from each knockout strain were compared against the KN99α 579 strain measured in the relevant experiment. P-values were obtained by comparing the two curves 580 using the G-rho family log-rank test [44] , implemented with the survdiff function. Ten C57BL/6 mice per group were anesthetized and inoculated intranasally with 1 × 10 3 586 KN99α, itr4Δ, or itr4Δ:ITR4 cells suspended in 50 μl PBS. Animals were treated as described 587 above. The itr4Δ that survived the infection initially showed early signs of disease (minor weight 588 loss, reduced activity) but regain weight at later timepoints. On day 44, the mice were sacrificed.
589
Lungs and brain were collected from each mouse to determine fungal burden, and processed as 590 described above.
591
For determination of CFUs at 7 days post-infection, 4 C57BL/6 mice per group were 592 anesthetized and inoculated intranasally with 1 × 10 3 KN99α, itr4Δ, or itr4Δ:ITR4 cells 593 suspended in 50 μl PBS. After seven days, the mice were sacrificed, and lungs and brain were controls, mixtures were kept at 0°C (on ice) during the 10-min incubation. Aliquots of 100 µl 616 were removed and transferred onto prewetted Metricel filters (1.2 µm) on a vacuum manifold.
617
The filters were washed four times each with 2 ml of ice-cold water. The washed filters were 618 removed and added to liquid scintillation vials for measurements on a PerkinElmer TRI-CARB 619 2900TR scintillation counter. the gene with the highest number of variants is indicated. Genes with more than 20 variants and named genes are indicated. Table S2 lists all genes with 10 or more variants. ST93A variants were more likely to be nonsynonymous and less likely to be downstream compared to ST93all or ST93B variants. C) IL2 cytokine levels in the CSF and in vitro macrophage uptake differed between ST93A and ST93B strains. Strains were tested in two separate experiments indicated as E1 or E2, respectively. mutant, and clinical strains on medium with different inositol levels. Yeast cells were cultured in YPD medium. Equal cell concentrations were spotted as 10-fold serial dilutions onto YNB plates made with 1% glucose, 1% inositol, or 1% glucose and 1% inositol. Plates were incubated at 30 o C and growth was examined after 4 days. The assay was repeated three times with similar results. D) Inositol uptake analysis of C. neoformans strains. Yeast cells were mixed with 3H-labeled inositol and incubated at 30 o C for 10 minutes in triplicate and repeated twice with similar patterns. Error bar indicates the standard deviation of the three replicates.
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